To date, numerous reports have suggested differential expression of ANXA1 depending on cancer type: up-regulation in esophageal cancer [5], pancreatic cancer[6], skin squamous cell carcinoma [7], and colon cancer [8] and down-regulation in cervical cancer [9], oral squamous cell carcinoma [10], and prostate cancer [11]. The gene discussed is ANXA1; the disease is cancer.